One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy.
about
One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
One-year efficacy of adjunctiv ...... with maximum medical therapy.
@en
One-year efficacy of adjunctiv ...... with maximum medical therapy.
@nl
type
label
One-year efficacy of adjunctiv ...... with maximum medical therapy.
@en
One-year efficacy of adjunctiv ...... with maximum medical therapy.
@nl
prefLabel
One-year efficacy of adjunctiv ...... with maximum medical therapy.
@en
One-year efficacy of adjunctiv ...... with maximum medical therapy.
@nl
P2093
P2860
P1476
One-year efficacy of adjunctiv ...... with maximum medical therapy.
@en
P2093
Hiroshi Inazaki
Hisayoshi Satoh
Kazuaki Kadonosono
Maiko Inoue
Satoshi Kobayashi
Shimpei Sato
Shin Yamane
Yoko Anzai
P2860
P2888
P304
P356
10.1007/S00417-017-3727-5
P577
2017-07-15T00:00:00Z